Back to Search
Start Over
EORTC-ROG expert opinion: Radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach
- Source :
- Radiotherapy and Oncology, Radiotherapy and Oncology, Elsevier, 2009, 92 (2), pp.164-175. 〈10.1016/j.radonc.2009.03.018〉, Radiotherapy and Oncology, Elsevier, 2009, 92 (2), pp.164-175. ⟨10.1016/j.radonc.2009.03.018⟩
- Publication Year :
- 2009
- Publisher :
- Elsevier BV, 2009.
-
Abstract
- International audience; PURPOSE: The Gastro-Intestinal Working Party of the EORTC Radiation Oncology Group (GIWP-ROG) developed guidelines for target volume definition in neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction (GEJ) and the stomach. METHODS AND MATERIALS: Guidelines about the definition of the clinical target volume (CTV) are based on a systematic literature review of the location and frequency of local recurrences and lymph node involvement in adenocarcinomas of the GEJ and the stomach. Therefore, MEDLINE was searched up to August 2008. Guidelines concerning prescription, planning and treatment delivery are based on a consensus between the members of the GIWP-ROG. RESULTS: In order to support a curative resection of GEJ and gastric cancer, an individualized preoperative treatment volume based on tumour location has to include the primary tumour and the draining regional lymph nodes area. Therefore we recommend to use the 2nd English Edition of the Japanese Classification of Gastric Carcinoma of the Japanese Gastric Cancer Association which developed the concept of assigning tumours of the GEJ and the stomach to anatomically defined sub-sites corresponding respectively to a distinct lymphatic spread pattern. CONCLUSION: The GIWP-ROG defined guidelines for preoperative irradiation of adenocarcinomas of the GEJ and the stomach to reduce variability in the framework of future clinical trials.
- Subjects :
- Oncology
medicine.medical_specialty
medicine.medical_treatment
MESH: Neoadjuvant Therapy
[SDV.CAN]Life Sciences [q-bio]/Cancer
Adenocarcinoma
[ SDV.CAN ] Life Sciences [q-bio]/Cancer
030218 nuclear medicine & medical imaging
MESH : Adenocarcinoma
03 medical and health sciences
0302 clinical medicine
MESH: Practice Guidelines as Topic
Stomach Neoplasms
Internal medicine
medicine
Humans
MESH : Esophagogastric Junction
MESH : Stomach Neoplasms
Radiology, Nuclear Medicine and imaging
Lymph node
Neoadjuvant therapy
MESH: Humans
business.industry
Stomach
MESH: Adenocarcinoma
MESH : Humans
Cancer
MESH: Stomach Neoplasms
Hematology
Esophageal cancer
medicine.disease
Neoadjuvant Therapy
3. Good health
Radiation therapy
Clinical trial
MESH : Practice Guidelines as Topic
medicine.anatomical_structure
030220 oncology & carcinogenesis
Practice Guidelines as Topic
MESH: Esophagogastric Junction
Esophagogastric Junction
business
MESH : Neoadjuvant Therapy
Subjects
Details
- ISSN :
- 01678140
- Volume :
- 92
- Database :
- OpenAIRE
- Journal :
- Radiotherapy and Oncology
- Accession number :
- edsair.doi.dedup.....05de63a7bbc63e622be0fb3a0ae1fb75
- Full Text :
- https://doi.org/10.1016/j.radonc.2009.03.018